Inhibition of Hepatitis B Virus Replication by the Interferon-Inducible MxA Protein
Emmanuel Gordien(Université Paris Cité), Dina Kremsdorf(Inserm), Olivier Rosmorduc(Assistance Publique – Hôpitaux de Paris), Cécile Peltekian(Inserm), Christian Bréchot(University of South Florida), Florianne Garreau(Inserm)
Cited by 185
Related Papers
Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis†
|Hepatology|2005|335
Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial
|The Lancet. Gastroenterology & hepatology|2017|249
Efficacy of peginterferon alpha-2b in chronic hepatitis delta: Relevance of quantitative RT-PCR for follow-up
|Hepatology|2006|238
Molecular Phylogenetic Analyses Indicate a Wide and Ancient Radiation of African Hepatitis Delta Virus, Suggesting a <i>Deltavirus</i> Genus of at Least Seven Major Clades
|Journal of Virology|2004|221
Eighth Major Clade for Hepatitis Delta Virus
|Emerging infectious diseases|2006|206